Moreover, medication for depression, such as using selective serotonin reuptake inhibitors for depression disorders, aggravates depression-associated DED, which results from the increase in tear serotonin levels and ocular surface inflammation via the NF-κB pathway (18). This evidence concerns the gene NFKB1 and major depressive disorder.